- Home
- VMD vs HRZN Comparison
VMD vs HRZN Comparison
Compare VMD & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | VMD | HRZN |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.5M | 275.7M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | VMD | HRZN |
|---|---|---|
| Price | $7.34 | $6.36 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.17 |
| AVG Volume (30 Days) | 147.9K | ★ 691.3K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 20.82% |
| EPS Growth | ★ 35.92 | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | ★ $254,794,000.00 | $98,899,000.00 |
| Revenue This Year | $20.05 | $3.03 |
| Revenue Next Year | $17.44 | $10.24 |
| P/E Ratio | $21.49 | ★ N/A |
| Revenue Growth | ★ 18.89 | N/A |
| 52 Week Low | $5.93 | $5.71 |
| 52 Week High | $8.62 | $9.99 |
Technical Indicators
Market Signals| Indicator | VMD | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 59.78 | 41.24 |
| Support Level | $7.24 | $6.27 |
| Resistance Level | $7.36 | $6.53 |
| Average True Range (ATR) | 0.20 | 0.11 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 63.10 | 17.71 |
Price Performance
Historical ComparisonAbout VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.